Pitfalls in developing new compounds for idiopathic pulmonary fibrosis Academic Article uri icon

Overview

MeSH Major

  • Idiopathic Pulmonary Fibrosis
  • Immunity, Innate
  • Microbiota

abstract

  • In this review, we attempt to synthesize how the field of IPF and clinical trials has evolved, the lessons learnt, and how these might inform and enable more efficient future clinical trial designs that are primed for success.

publication date

  • September 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/MCP.0000000000000407

PubMed ID

  • 28771451

Additional Document Info

start page

  • 426

end page

  • 431

volume

  • 23

number

  • 5